Topraz 4mg, 5mg, 10mg Chewable tablet, FC tablet
PDF Leaflet Revision Date: 24 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma.
Dosage (summary)
Adults and children 15+: 10 mg daily; 6-14 years: 5 mg daily; 2-5 years: 4 mg daily.
Onset of Action / Duration
Onset: 1 day, Duration: Not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; avoid breastfeeding.
Key Drug Interactions
- Phenobarbital
- Gemfibrozil
- CYP inducers/inhibitors
Contraindications
- Hypersensitivity to montelukast
- Children under 2 years
- Children under 6 years for TOPRAZ 5
- Children under 15 years for TOPRAZ 10
Common side effects
- Headache
- Upper respiratory tract infections
- Rash
Counselling Points
- Take daily as prescribed
- Have rescue medication available
- Report any mood changes
Serious warnings
- Not for acute asthma attacks
- Neuropsychiatric events
- Eosinophilic conditions
Important Disclaimer
The Topraz 4mg, 5mg, 10mg Chewable tablet, FC tablet professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
